CL2016002276A1 - Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad - Google Patents

Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad

Info

Publication number
CL2016002276A1
CL2016002276A1 CL2016002276A CL2016002276A CL2016002276A1 CL 2016002276 A1 CL2016002276 A1 CL 2016002276A1 CL 2016002276 A CL2016002276 A CL 2016002276A CL 2016002276 A CL2016002276 A CL 2016002276A CL 2016002276 A1 CL2016002276 A1 CL 2016002276A1
Authority
CL
Chile
Prior art keywords
extract
coriolus versicolor
topical compositions
cervical
vaginal
Prior art date
Application number
CL2016002276A
Other languages
English (en)
Inventor
Dominguez Fernando Losa
Santiago Palacios
Yann Gaslain
Original Assignee
Procare Health Iberia S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50287915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016002276(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procare Health Iberia S L filed Critical Procare Health Iberia S L
Publication of CL2016002276A1 publication Critical patent/CL2016002276A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

<p>La presente invención proporciona una composición tópica que comprende un extracto de Coriolus versicolor para su uso en la prevención y/o el tratamiento mediante administración vaginal o cervical de un trastorno vaginal y/o cervical que es causado por un agente infeccioso, en particular infecciones por el virus del papiloma humano y trastornos relacionados, incluyendo el cáncer cervical. La composición de la invención actúa potenciando la inmunidad genital frente a agentes infecciosos y reepitelizando el</p>
CL2016002276A 2014-03-13 2016-09-08 Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad CL2016002276A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14159640 2014-03-13

Publications (1)

Publication Number Publication Date
CL2016002276A1 true CL2016002276A1 (es) 2017-06-09

Family

ID=50287915

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002276A CL2016002276A1 (es) 2014-03-13 2016-09-08 Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad

Country Status (16)

Country Link
US (2) US10874702B2 (es)
EP (1) EP3116519B1 (es)
AU (1) AU2015228775B2 (es)
CA (1) CA2940273C (es)
CL (1) CL2016002276A1 (es)
DK (1) DK3116519T3 (es)
ES (1) ES2738377T3 (es)
HR (1) HRP20191355T1 (es)
HU (1) HUE044472T2 (es)
LT (1) LT3116519T (es)
MX (1) MX369474B (es)
PL (1) PL3116519T3 (es)
PT (1) PT3116519T (es)
SI (1) SI3116519T1 (es)
TR (1) TR201911232T4 (es)
WO (1) WO2015136096A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6443278B2 (ja) * 2015-09-10 2018-12-26 豊田合成株式会社 ステアリングホイール
US11045519B2 (en) * 2017-01-31 2021-06-29 Unm Rainforest Innovations Arginine-rich polypeptide compositions and methods of using same
DE102017121066A1 (de) * 2017-08-07 2019-02-07 Boris Vestweber Zusammensetzung, insbesondere zur Pflege des Intim- oder Vaginalbereichs
CN110013465A (zh) * 2018-01-09 2019-07-16 宿迁市第一人民医院 一种和厚朴酚脂质体及其制备方法和应用
CN110101655A (zh) * 2019-05-31 2019-08-09 杨平芝 一种修复宫颈及预防细菌性阴道炎的组合物
CN115768452A (zh) * 2020-04-28 2023-03-07 伊比利亚护理健康有限公司 用于治疗由传染性病原体引起的阴道或宫颈病症的云芝提取物
IT202000014911A1 (it) * 2020-06-22 2021-12-22 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni vaginali
CN112022800B (zh) * 2020-09-21 2023-06-09 南京北极光生物科技有限公司 一种组合物和该组合物制备的阴道凝胶及其在抗人乳头瘤病毒中的应用
IT202100004214A1 (it) * 2021-02-23 2022-08-23 Zetemia S R L Composizione farmaceutica per il trattamento di infezioni da hpv
US20240299338A1 (en) * 2021-06-13 2024-09-12 Innocan Pharma Ltd. Compositions for treatment of vaginal atrophy
EP4342481A1 (en) 2022-09-26 2024-03-27 Hifas da Terra SL Use of an extract of hericium erinaceus for the treatment of vaginal and cervical diseases
WO2024182816A2 (en) * 2023-03-02 2024-09-06 University Of South Florida Short interspersed nuclear repeat element rna of imprinted micro-rna clusters mediate intrinsic type iii interferon-driven viral resistance
CN117137938B (zh) * 2023-09-08 2024-04-05 广州小蛮腰医疗器械有限公司 用于阴道损伤修复的药物组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1067861C (zh) * 1998-09-11 2001-07-04 王扬 芦荟面制食品及其制造方法
US8765138B2 (en) 2004-01-06 2014-07-01 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
KR20030082619A (ko) 2002-04-17 2003-10-23 종근당건강 주식회사 면역 활성 증강용 조성물
AU2003269928A1 (en) * 2003-03-06 2004-09-30 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising prenyl flavonoids
KR20060097847A (ko) * 2005-03-07 2006-09-18 주식회사 코오롱 히알루론산을 포함하는 식품
HUP0500582A1 (hu) * 2005-06-13 2007-08-28 Csaba Jozsef Dr Jaszberenyi Szinergetikus élettani hatású élelmiszerek, élelmiszer-adalékok és táplálék-kiegészítõk vagy takarmányadalékok
US8916541B2 (en) * 2011-01-05 2014-12-23 Better Health Publishing, Inc. Synergistic combination of honokiol and modified citrus pectin in cancer therapy
US20080124303A1 (en) 2005-12-12 2008-05-29 Cavit Sciences, Inc Methods and compositions for treatment of viral infections
WO2007131973A2 (en) * 2006-05-11 2007-11-22 Prendergast Patrick T Compositions and methods for modulating the immune system
EP2051698A1 (en) * 2006-07-18 2009-04-29 D.M.G. Italia Srl A liposomal complex of sodium carboxymethyl beta-glucan
BRPI0701208A2 (pt) * 2007-03-26 2008-11-11 Wilton Viana processo de obtenÇço de suplemento alimentar e produto assim obtido
US7854936B2 (en) 2008-01-14 2010-12-21 Active Organics, Inc. Anti-inflammatory hydrolysate of C. versicolor
FR2949684B1 (fr) * 2009-09-04 2011-12-16 Silab Sa Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau
CO6270030A1 (es) 2009-10-02 2011-04-20 Pontificia Universidad Javeriana Fraccion bioactiva de petivera alliacea composicion farmaceutica que la contiene y combinacion con agentes inmunoestimulantes para el tratamiento de cancer
WO2011094579A2 (en) * 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP2012075390A (ja) * 2010-10-01 2012-04-19 Kiyotoshi Oshiro 乳酸菌醗酵モズクとその製造方法
CN103298476A (zh) * 2010-10-06 2013-09-11 培力有限公司 采绒革盖菌提取物及其制备方法和用途

Also Published As

Publication number Publication date
ES2738377T3 (es) 2020-01-22
MX369474B (es) 2019-11-08
US11524039B2 (en) 2022-12-13
PT3116519T (pt) 2019-08-06
TR201911232T4 (tr) 2019-08-21
DK3116519T3 (da) 2019-08-05
US20170014459A1 (en) 2017-01-19
AU2015228775A1 (en) 2016-10-20
EP3116519B1 (en) 2019-05-08
MX2016011667A (es) 2017-02-08
CA2940273C (en) 2022-12-06
WO2015136096A1 (en) 2015-09-17
US10874702B2 (en) 2020-12-29
HUE044472T2 (hu) 2019-10-28
PL3116519T3 (pl) 2019-12-31
AU2015228775B2 (en) 2020-04-02
CA2940273A1 (en) 2015-09-17
EP3116519A1 (en) 2017-01-18
US20210085738A1 (en) 2021-03-25
HRP20191355T1 (hr) 2019-11-01
LT3116519T (lt) 2019-08-26
SI3116519T1 (sl) 2019-09-30

Similar Documents

Publication Publication Date Title
MX369474B (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad.
CL2018000222A1 (es) Nueva combinación para el uso en el tratamiento del cáncer
MX390954B (es) Composiciones que comprenden una combinacion de un anticuerpo anti muerte programada 1 (pd-1) y otro anticuerpo.
MX2019009443A (es) Metodos para tratar la influenza.
CL2019000935A1 (es) Composición farmacéutica, métodos para tratamiento y usos de la misma.
CL2017003151A1 (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
AR099632A1 (es) Tratamiento de una infección viral de hepatitis c, que usa una combinación de compuestos
MX2016007658A (es) Composiciones basadas en metil ciclodextrinas para el tratamiento y/o prevencion de enfermedades aumentando el nivel de colesterol hdl.
BR112016013109A2 (pt) anticorpos de anti-siglec-8 e métodos de seu uso
PH12015501156A1 (en) Pharmaceutical compositions
IN2013MU03583A (es)
PE20151588A1 (es) Vacuna contra el virus del dengue
MX2016015437A (es) Combinacion que comprende un glucocorticoide y edo-s101.
CL2015002466A1 (es) Formulaciones de compuestos orgánicos
WO2015095735A3 (en) Vaccine compositions and uses thereof
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
CL2019000625A1 (es) Combinación de agonistas de fxr.
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX2017001396A (es) Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontan que utilizan composiciones de udenafilo.
EA201590678A1 (ru) Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w
UY35890A (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington